NCT05206708 Assesment of the Efficacy of Personalized Parent-child Psychotherapy in Children Under 3 Years Old
| NCT ID | NCT05206708 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Besancon |
| Condition | Child Behavior Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 234 participants |
| Start Date | 2022-02-28 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 234 participants in total. It began in 2022-02-28 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess the efficacy at 4 months of a personalized strategy comparatively to a standard Psychodynamic Integrative Therapy, on childrens' symptom improvment
Eligibility Criteria
Inclusion Criteria: * Families who are requesting a consultation for functional or behavioural problems of their child * Children under the age of 3 Exclusion Criteria: * Parents suffering from a severe untreated psychiatric disorder * Difficulties in speaking French * Children with Autistic spectrum disorder * Families already in care
Contact & Investigator
Lauriane Coady-Vulliez, MD
PRINCIPAL INVESTIGATOR
CHU Besançon
Frequently Asked Questions
Who can join the NCT05206708 clinical trial?
This trial is open to participants of all sexes, up to 3 Years, studying Child Behavior Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05206708 currently recruiting?
Yes, NCT05206708 is actively recruiting participants. Contact the research team at mszymanska@chu-besancon.fr for enrollment information.
Where is the NCT05206708 trial being conducted?
This trial is being conducted at Besançon, France, Montpellier, France, Paris, France, Reims, France.
Who is sponsoring the NCT05206708 clinical trial?
NCT05206708 is sponsored by Centre Hospitalier Universitaire de Besancon. The principal investigator is Lauriane Coady-Vulliez, MD at CHU Besançon. The trial plans to enroll 234 participants.